Dr. Nirav S. Dhruva

Claim this profile

Rex Hematology Oncology Associates-Cary

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
2 drugs studied

Area of expertise

1Lung Cancer
Nirav S. Dhruva has run 2 trials for Lung Cancer. Some of their research focus areas include:
RET positive
Stage IV
Stage I
2Non-Small Cell Lung Cancer
Nirav S. Dhruva has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
RET positive
Stage IV
Stage I

Affiliated Hospitals

Image of trial facility.
Rex Hematology Oncology Associates-Cary
Image of trial facility.
Rex Hematology Oncology Associates-Garner

Clinical Trials Nirav S. Dhruva is currently running

Image of trial facility.

Targeted Therapy Screening

for Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria

More about Nirav S. Dhruva

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Nirav S. Dhruva has experience with
  • Selpercatinib
  • Screening Platform
Breakdown of trials Nirav S. Dhruva has run
Lung Cancer
Non-Small Cell Lung Cancer

Other Doctors you might be interested in

Lisa CareyUniversity of North Carolina
Ranjit JosephRex Hematology Oncology Associates-Cary
JoEllen SpecaUNC Rex Healthcare

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nirav S. Dhruva specialize in?
Nirav S. Dhruva focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved RET positive patients, or patients who are Stage IV.
Is Nirav S. Dhruva currently recruiting for clinical trials?
Yes, Nirav S. Dhruva is currently recruiting for 1 clinical trial in Cary North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Nirav S. Dhruva has studied deeply?
Yes, Nirav S. Dhruva has studied treatments such as Selpercatinib, Screening Platform.
What is the best way to schedule an appointment with Nirav S. Dhruva?
Apply for one of the trials that Nirav S. Dhruva is conducting.
What is the office address of Nirav S. Dhruva?
The office of Nirav S. Dhruva is located at: Rex Hematology Oncology Associates-Cary, Cary, North Carolina 27518 United States. This is the address for their practice at the Rex Hematology Oncology Associates-Cary.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top